RA Capital Management, L.P. 13D/13G Filings for Aerovate Therapeutics, Inc. (AVTE)

RA Capital Management, L.P. 13D and 13G filings for Aerovate Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-06-20
6:00 pm
Purchase
2024-06-1713DAerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P.264,060
32.000%
26,517increase
(+11.16%)
Filing
2024-04-30
4:16 pm
Purchase
2024-04-2613DAerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P.237,542
28.900%
595increase
(+0.25%)
Filing
2023-06-27
5:00 pm
Purchase
2023-06-2613DAerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P.236,947
30.000%
833increase
(+0.35%)
Filing
2021-07-12
5:13 pm
Purchase
2021-07-0213DAerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P.236,114
33.900%
236,114increase
(New Position)
Filing